The Impact of Cycle for Survival
$30 million raised in 2023
Today, these funds are helping MSK doctors and scientists turn ideas once thought impossible into reality.
Every dollar fuels progress
100% of all funds raised through Cycle for Survival go directly to rare cancer research and clinical trials at MSK.
Accelerating innovation
The money raised during each event season is awarded to MSK doctors and scientists just six months after fundraising ends. This exceptionally fast timeline ensures that these much-needed resources can make an impact right away.
MSK’s world-leading expertise
MSK is home to clinical experts in more than 400 types of cancer — including types so rare that many hospitals have never treated people with these diseases. The specialized care that MSK provides truly makes a difference for people with a rare cancer.
The support provided through Cycle for Survival is critical to advancing the most bold and innovative science and enables us to make rapid progress.
–Vinod Balachandran, MD
From bold ideas to lifesaving innovations
Some of the research we support
Every dollar raised by our community gives MSK doctors and scientists the resources they need to answer the biggest questions about rare cancers, develop better treatments, harness powerful technology to make new discoveries, and so much more.
Bringing rare cancers into focus
Rare cancers include brain, ovarian, and pancreatic cancers; leukemia and lymphoma; sarcoma; and all pediatric cancers. Cycle for Survival supports research at MSK that brings rare cancers into the spotlight.
Discovering new treatments
People with a rare cancer too often are faced with a lack of dedicated treatment options, limited research, and fewer opportunities to participate in clinical trials. Cycle for Survival funds are helping change that.
Harnessing the power of data
Cycle for Survival drives collaboration between computational scientists and clinical experts at MSK, both of whom use innovative methods and powerful technology to analyze complex data to learn even more about rare cancers.
Transforming diagnostics
MSK-IMPACT® and MSK-ACCESS® are next-generation sequencing tests that Cycle for Survival funding helped develop. They allow doctors to more accurately diagnose people with a rare cancer and match them to the best treatment.
Accelerating discovery
Cycle for Survival funds equip MSK scientists with gold-standard technologies that lead to new discoveries faster, ensuring that MSK remains at the forefront of rare cancer research and care for many years to come.
Join the movement to beat rare cancers
Sign up for a ride
Start your own fundraiser
Donate
Corporate support
